1. 144PClinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs. (13th April 2019) Authors: Passaro, A; Prelaj, A; Spitaleri, G; Del Signore, E; Rossi, G; Guerini-Rocco, E; Barberis, M; Catania, C; de Marinis, F Journal: Annals of oncology Issue: Volume 30(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗